Trovagene announced that the initial patient successfully completed the first cycle 1 of treatment in its Phase 1b/2 multicenter trial
of PCM-075 in combination with low-dose cytarabine in patients with Acute Myeloid Leukemia .
NASDAQ: TROV) has added two institutions, Yale Cancer Center and Kansas University Cancer Center to conduct its Phase 1b/2 open-label, multicenter trial
of PCM-075 in patients with acute myeloid leukemia (AML), the company said.
According to the company, Actimab-A is in clinical development in a Phase 1/2 trial for newly diagnosed AML patients over the age of 60 in a single arm multicenter trial
The multicenter trial
enrolled 12 patients with heart failure who received JVS-100 at 30 mg or 45 mg via retrograde infusion.
Ginsenoside-RD improves the outcome of acute ischaemic stroke", is the randomized double blind placebo-controlled multicenter trial
by Liu et al which described that Ginseniside-RD, a receptor operated calcium channel antagonist that improved the functional outcome in patients with acute ischaemic stroke.
The Phase 2 open label, single-arm, multicenter trial
plans to enroll approximately 80 patients with AR-positive, TNBC at sites in the United States, Canada and Europe.
However, the HeartWare pump is currently under evaluation for destination therapy in the randomized multicenter trial
A randomized, placebo-controlled, double-blind, parallel-group, multicenter trial
was conducted in 26 ICUs in France.
The multicenter trial
at seven institutions, including Johns Hopkins, enrolled prostate cancer patients whose disease had spread to take a once-daily pill for four weeks.
Daily supplementation with vitamins C and E starting between 9 and 16 weeks' gestation did not reduce the rate of pregnancy-associated hypertension, according to a large multicenter trial
in low-risk, nulliparous women.
Radiofrequency ablation (RFA) has been found to generate a complete response in a high percentage of patients in an industry-sponsored, prospective, single-arm, multicenter trial
involving patients with early-stage non-small cell lung cancer (NSCLC) or pulmonary metastases (overall tumor size < 3.
Data collected for each article were number of authors, ordinal number of the corresponding author, type of study described, whether the described study was a multicenter trial
, whether authorship listed included a "study group," and whether any author was also an editor of the journal.